Summary of the Conference Call for Furuida Company Overview - **Company**: Furuida - **Brands**: Aier Doctor, Yilian, Kemei Key Points and Arguments Brand Adjustments and Performance - Aier Doctor brand is undergoing adjustments expected to complete by the end of 2025, with current performance anticipated to remain flat due to market price issues and product discontinuation [2][3] - The new 287 mask, an upgraded version of the probiotic mask, is expected to drive growth in the second half of the year [2][16] - Yilian brand has completed its upgrade, focusing on high-moisture ingredients, and is projected to achieve double-digit growth by 2025 [2][4] - Kemei brand has made breakthroughs in transdermal technology, allowing collagen to be absorbed through the skin, with expectations of triple-digit growth by 2025 [2][5] Financial Projections - Overall revenue for Furuida in 2025 is expected to be flat or slightly increase, with Yilian projected to grow by 15% to 20% and Kemei by triple digits [2][6][8] - Aier Doctor's performance is expected to stabilize after adjustments, with optimism for 2026 if the brand's strategy is successful [6][8] Product Innovations - Introduction of new ingredient royal jelly acid, which has anti-aging and repair functions, planned for launch under Aier Doctor in July [2][12][13] - The new product series will include various skincare items priced competitively compared to luxury brands [14][36] Market Strategy - Furuida's online sales channels are currently at a ratio of 9:1 compared to offline, with plans to adjust to 80% online and 20% offline [19] - The company is focusing on high-margin products and reducing reliance on external raw materials to improve profitability, especially on platforms like Douyin [20] Challenges and Opportunities - The company faces challenges with Aier Doctor's brand performance but is actively addressing issues such as channel pricing and product strategy [3][7] - Furuida is exploring acquisition opportunities to expand into new markets and enhance its product offerings [25][26] Consumer Engagement - The company is leveraging live streaming and offline events to promote new products, aiming to enhance brand awareness and consumer engagement [27][28] Future Outlook - Furuida is optimistic about the market response to new products, particularly the royal jelly acid series, which is currently in testing [17] - The company is committed to maintaining stable growth in its pharmaceutical and raw material sectors while exploring new product lines [22][21] Additional Important Information - The company is not currently considering selling exclusive raw materials but is open to other forms of collaboration [15] - Kemei's current sales strategy includes a focus on online channels, with a strong average transaction value of 699 yuan in live streaming [9][10] - The company is also testing new health products in the oral collagen segment, responding to growing consumer interest in wellness [21]